FDA Bill Shows Risk Of Inexact Statute Text, Post-Loper Bright
By Todd Harrison and Alexander Rubel · September 29, 2026, 3:47 PM EDT
H.R. 10336, the Dietary Supplement Innovation Act, addresses a genuine problem in the Federal Food, Drug and Cosmetic Act's drug preclusion framework.[1] Its clinical investigation trigger, however, shows why textual precision...
To view the full article, register now.